Zhi Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhi Liu has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Ning Li
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599
7 shared publicationsBin-Jin Hwang
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599
4 shared publications- Luis A. Diaz
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC
4 shared publications Jinbo Chen
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC
3 shared publications- Nancy E. Thomas
University of North Carolina at Chapel Hill
3 shared publications - Paul B. Googe
Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA
3 shared publications
Latest Publications
- Open Access
- 12 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa
Background: Hidradenitis suppurativa (HS) is a common, chronic and debilitating inflammatory disease that most commonly affects intertriginous skin. Despite its high heritability, the genetic underpinnings of HS remain poorly understood. Objectives: To identify genetic signals associated with HS, determine genetic relationships with other diseases and investigate potential molecular genetic mechanisms. Methods: We performed a genome-wide association meta-analysis of six studies, totalling 4540 patients with HS and > 1 million control participants, and identified genetic correlations with other common diseases. We integrated the HS data with expression quantitative trait loci from 10 trait-relevant tissues, epigenomic and transcriptomic data from human scalp, differential expression data from HS lesions vs. adjacent skin and mesenchymal Hi-C chromatin looping data. To identify functional noncoding variants, we performed transcriptional reporter assays for signals near KLF5 and SOX9. Results: We identified 11 significant HS signals across 7 loci: 4 corresponded to previously reported associations, 4 represented novel signals within known loci and 3 were signals in newly implicated loci. We identified significant genetic correlations between HS and other inflammatory conditions, particularly inflammatory bowel disease, rheumatoid arthritis, type 2 diabetes mellitus and asthma. We prioritized candidate genes for the 11 signals. The risk allele at KLF5 exhibited 10-fold greater transcriptional activity than the nonrisk allele, while risk alleles at SOX9 showed significantly reduced transcriptional activity. Conclusions: Our results provide insights into potential genetic mechanisms underlying HS and suggest potential therapeutic targets for this challenging condition.
- 12 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessGenomic loci and molecular genetic mechanisms for hidradenitis suppurativa
Background: Hidradenitis suppurativa (HS) is a common, chronic and debilitating inflammatory disease that most commonly affects intertriginous skin. Despite its high heritability, the genetic underpinnings of HS remain poorly understood. Objectives: To identify genetic signals associated with HS, determine genetic relationships with other diseases and investigate potential molecular genetic mechanisms. Methods: We performed a genome-wide association meta-analysis of six studies, totalling 4540 patients with HS and > 1 million control participants, and identified genetic correlations with other common diseases. We integrated the HS data with expression quantitative trait loci from 10 trait-relevant tissues, epigenomic and transcriptomic data from human scalp, differential expression data from HS lesions vs. adjacent skin and mesenchymal Hi-C chromatin looping data. To identify functional noncoding variants, we performed transcriptional reporter assays for signals near KLF5 and SOX9. Results: We identified 11 significant HS signals across 7 loci: 4 corresponded to previously reported associations, 4 represented novel signals within known loci and 3 were signals in newly implicated loci. We identified significant genetic correlations between HS and other inflammatory conditions, particularly inflammatory bowel disease, rheumatoid arthritis, type 2 diabetes mellitus and asthma. We prioritized candidate genes for the 11 signals. The risk allele at KLF5 exhibited 10-fold greater transcriptional activity than the nonrisk allele, while risk alleles at SOX9 showed significantly reduced transcriptional activity. Conclusions: Our results provide insights into potential genetic mechanisms underlying HS and suggest potential therapeutic targets for this challenging condition.
- 6 September 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (8) , 1216-1223
The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid
Bullous pemphigoid (BP) is the most common autoimmune bullous skin disease of humans and is characterized by eosinophilic inflammation and circulating and tissue-bound IgG and IgE autoantibodies directed against two hemidesmosomal proteins: BP180 and BP230. The noncollagenous 16A domain (NC16A) of BP180 has been found to contain major epitopes recognized by autoantibodies in BP. We recently established the pathogenicity of anti-NC16A IgE through passive transfer of patient-derived autoantibodies to double-humanized mice that express the human high-affinity IgE receptor, FcεRI, and human NC16A domain (FcεRI/NC16A). In this model, anti-NC16A IgEs recruit eosinophils to mediate tissue injury and clinical disease in FcεRI/NC16A mice. The objective of this study was to characterize the molecular and cellular events that underlie eosinophil recruitment and eosinophil-dependent tissue injury in anti-NC16A IgE-induced BP. We show that anti-NC16A IgEs significantly increase levels of key eosinophil chemoattractants, eotaxin-1 and eotaxin-2, as well as the proteolytic enzyme matrix metalloproteinase-9 (MMP-9) in the lesional skin of FcεRI/NC16A mice. Importantly, neutralization of eotaxin-1, but not eotaxin-2, and blockade of the main eotaxin receptor, CCR3, drastically reduce anti-NC16A IgE-induced disease activity. We further show that anti-NC16A IgE/NC16A immune complexes induce the release of MMP-9 from eosinophils, and that MMP-9–deficient mice are resistant to anti-NC16A IgE-induced BP. Lastly, we find significantly increased levels of eotaxin-1, eotaxin-2, and MMP-9 in blister fluids of BP patients. Taken together, this study establishes the eotaxin-1/CCR3 axis and MMP-9 as key players in anti-NC16A IgE-induced BP and candidate therapeutic targets for future drug development and testing.
- 6 September 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (8) , 1216-1223
The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid
Bullous pemphigoid (BP) is the most common autoimmune bullous skin disease of humans and is characterized by eosinophilic inflammation and circulating and tissue-bound IgG and IgE autoantibodies directed against two hemidesmosomal proteins: BP180 and BP230. The noncollagenous 16A domain (NC16A) of BP180 has been found to contain major epitopes recognized by autoantibodies in BP. We recently established the pathogenicity of anti-NC16A IgE through passive transfer of patient-derived autoantibodies to double-humanized mice that express the human high-affinity IgE receptor, FcεRI, and human NC16A domain (FcεRI/NC16A). In this model, anti-NC16A IgEs recruit eosinophils to mediate tissue injury and clinical disease in FcεRI/NC16A mice. The objective of this study was to characterize the molecular and cellular events that underlie eosinophil recruitment and eosinophil-dependent tissue injury in anti-NC16A IgE-induced BP. We show that anti-NC16A IgEs significantly increase levels of key eosinophil chemoattractants, eotaxin-1 and eotaxin-2, as well as the proteolytic enzyme matrix metalloproteinase-9 (MMP-9) in the lesional skin of FcεRI/NC16A mice. Importantly, neutralization of eotaxin-1, but not eotaxin-2, and blockade of the main eotaxin receptor, CCR3, drastically reduce anti-NC16A IgE-induced disease activity. We further show that anti-NC16A IgE/NC16A immune complexes induce the release of MMP-9 from eosinophils, and that MMP-9–deficient mice are resistant to anti-NC16A IgE-induced BP. Lastly, we find significantly increased levels of eotaxin-1, eotaxin-2, and MMP-9 in blister fluids of BP patients. Taken together, this study establishes the eotaxin-1/CCR3 axis and MMP-9 as key players in anti-NC16A IgE-induced BP and candidate therapeutic targets for future drug development and testing.
- 10 July 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 24-32.e1
Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice
- 10 July 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 24-32.e1
Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice
- 23 September 2022
- Published by Morressier GmbH
ESDR070 - Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod
Efgartigimod (EFG) is an engineered Fc fragment that inhibits the activity of the neonatal Fc receptor (FcRn), thereby reducing the levels of cir | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR070 - Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod
Efgartigimod (EFG) is an engineered Fc fragment that inhibits the activity of the neonatal Fc receptor (FcRn), thereby reducing the levels of cir | POSTER
- 15 November 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (10) , 2786-2794
Non–Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice
BP180 (also termed type XVII collagen) is a hemidesmosomal protein and plays a critical role in cell–cell matrix adhesion in the skin; however, its other biological functions are largely unclear. In this study, we generated a BP180 functional–deficient mouse strain by deleting its extracellular domain of humanized NC16A (termed ΔNC16A mice). We found that BP180 is expressed by bone marrow mesenchymal stem cells (BM-MSC), and its functional deficiency leads to myeloid hyperplasia. Altered granulopoiesis in ΔNC16A mice is through bone marrow stromal cells evidenced by bone marrow transplantation. Furthermore, the level of G-CSF in bone marrow and circulation were significantly increased in ΔNC16A mice as compared with wild-type mice. The increased G-CSF was accompanied by an increased activation of the NF-κB signaling pathway in bone marrow and BM-MSC of ΔNC16A mice. Blockade of G-CSF restored normal granulopoiesis in ΔNC16A mice. Inhibition of NF-κB signaling pathway significantly reduces the release of G-CSF from ΔNC16A BM-MSC in vitro and the level of serum G-CSF in ΔNC16A mice. To our knowledge, these findings provide the first direct evidence that BP180 plays an important role in granulopoiesis through regulating NF-κB signaling pathway in BM-MSC. Key Points BP180 is expressed in bone marrow mesenchymal stem cells. BP180 in bone marrow mesenchymal stem cells regulates granulopoiesis.
- 15 November 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (10) , 2786-2794
Non–Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice
BP180 (also termed type XVII collagen) is a hemidesmosomal protein and plays a critical role in cell–cell matrix adhesion in the skin; however, its other biological functions are largely unclear. In this study, we generated a BP180 functional–deficient mouse strain by deleting its extracellular domain of humanized NC16A (termed ΔNC16A mice). We found that BP180 is expressed by bone marrow mesenchymal stem cells (BM-MSC), and its functional deficiency leads to myeloid hyperplasia. Altered granulopoiesis in ΔNC16A mice is through bone marrow stromal cells evidenced by bone marrow transplantation. Furthermore, the level of G-CSF in bone marrow and circulation were significantly increased in ΔNC16A mice as compared with wild-type mice. The increased G-CSF was accompanied by an increased activation of the NF-κB signaling pathway in bone marrow and BM-MSC of ΔNC16A mice. Blockade of G-CSF restored normal granulopoiesis in ΔNC16A mice. Inhibition of NF-κB signaling pathway significantly reduces the release of G-CSF from ΔNC16A BM-MSC in vitro and the level of serum G-CSF in ΔNC16A mice. To our knowledge, these findings provide the first direct evidence that BP180 plays an important role in granulopoiesis through regulating NF-κB signaling pathway in BM-MSC. Key Points BP180 is expressed in bone marrow mesenchymal stem cells. BP180 in bone marrow mesenchymal stem cells regulates granulopoiesis.
- 21 August 2019
- Published by Springer Nature in Oncogene
- Vol. 38 (50) , 7491-7503
The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression
BP180, also termed collagen XVII, is a hemidesmosomal transmembrane glycoprotein expressed in basal keratinocytes, and functions as a cell–matrix adhesion molecule in the dermal–epidermal junction of the skin. Its function, other than cell–matrix adhesion, remains unclear. We generated a mouse strain with BP180 dysfunction (termed ∆NC16A), which develops spontaneous skin inflammation accompanied by an influx of myeloid derived suppressor cells (MDSCs). We used the B16 mouse melanoma model to demonstrate that BP180 dysfunction in either skin or basal keratinocytes promotes MDSC influx into skin and tumor progression. MDSC depletion reduced tumor progression in ∆NC16A mice, demonstrating a critical role for BP180 dysfunction-driven MDSCs in melanoma progression. This study provides the first direct evidence that BP180, a cell–cell matrix adhesion molecule, possesses antitumor function through modulating infiltration of MDSCs. Basal keratinocytes actively participate in skin microenvironment changes caused by BP180 dysfunction. ∆NC16A mice could be a new animal model to study the melanoma microenvironment.
- 21 August 2019
- Published by Springer Nature in Oncogene
- Vol. 38 (50) , 7491-7503
The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression
BP180, also termed collagen XVII, is a hemidesmosomal transmembrane glycoprotein expressed in basal keratinocytes, and functions as a cell–matrix adhesion molecule in the dermal–epidermal junction of the skin. Its function, other than cell–matrix adhesion, remains unclear. We generated a mouse strain with BP180 dysfunction (termed ∆NC16A), which develops spontaneous skin inflammation accompanied by an influx of myeloid derived suppressor cells (MDSCs). We used the B16 mouse melanoma model to demonstrate that BP180 dysfunction in either skin or basal keratinocytes promotes MDSC influx into skin and tumor progression. MDSC depletion reduced tumor progression in ∆NC16A mice, demonstrating a critical role for BP180 dysfunction-driven MDSCs in melanoma progression. This study provides the first direct evidence that BP180, a cell–cell matrix adhesion molecule, possesses antitumor function through modulating infiltration of MDSCs. Basal keratinocytes actively participate in skin microenvironment changes caused by BP180 dysfunction. ∆NC16A mice could be a new animal model to study the melanoma microenvironment.
- 2 November 2018
- Published by Wiley in British Journal of Dermatology
- Vol. 179 (5) , 1030
Is peripheral eosinophilia associated with the different morphological characteristics of bullous pemphigoid?
- 2 November 2018
- Published by Wiley in British Journal of Dermatology
- Vol. 179 (5) , 1030
Is peripheral eosinophilia associated with the different morphological characteristics of bullous pemphigoid?
- 4 June 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (25) , 6434-6439
BP180 dysfunction triggers spontaneous skin inflammation in mice
Significance: BP180 is a cell–cell matrix adhesion molecule and is critical for attachment of epidermis to underlying dermis. We generated a dysfunctional BP180 mouse strain (Δ NC16A mice). The Δ NC16A mice at 8 weeks start developing spontaneous itch and skin inflammation characterized by increased skin thickness, infiltrating immune cells, increased levels of IgE in circulation, proinflammatory mediators in the skin, and impaired skin barrier. Bullous pemphigoid (BP) patients also present increased TSLP in lesional skin and circulation. Our findings suggest that BP180 regulates pruritic skin inflammation. Elucidation of molecular and cellular mechanisms underlying the role of BP180 in skin inflammation should help better understanding of pathophysiology of skin inflammation and identify therapeutic targets for skin inflammatory diseases such as BP and atopic dermatitis.
- 4 June 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (25) , 6434-6439
BP180 dysfunction triggers spontaneous skin inflammation in mice
Significance: BP180 is a cell–cell matrix adhesion molecule and is critical for attachment of epidermis to underlying dermis. We generated a dysfunctional BP180 mouse strain (Δ NC16A mice). The Δ NC16A mice at 8 weeks start developing spontaneous itch and skin inflammation characterized by increased skin thickness, infiltrating immune cells, increased levels of IgE in circulation, proinflammatory mediators in the skin, and impaired skin barrier. Bullous pemphigoid (BP) patients also present increased TSLP in lesional skin and circulation. Our findings suggest that BP180 regulates pruritic skin inflammation. Elucidation of molecular and cellular mechanisms underlying the role of BP180 in skin inflammation should help better understanding of pathophysiology of skin inflammation and identify therapeutic targets for skin inflammatory diseases such as BP and atopic dermatitis.
- 1 June 2018
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 138 (6) , 1249-1251
Modes of Action of Intravenous Immunoglobulin in Bullous Pemphigoid
- 1 June 2018
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 138 (6) , 1249-1251
Modes of Action of Intravenous Immunoglobulin in Bullous Pemphigoid
- 1 May 2018
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 138 (5) , 1032-1043
Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid
- 1 May 2018
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 138 (5) , 1032-1043
Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid